Stage III Ovarian Cancer AJCC v6 and v7 Active Not Recruiting Phase 0 Trials for Talazoparib (DB11760)

IndicationStatusPhase
DBCOND0093245 (Stage III Ovarian Cancer AJCC v6 and v7)Active Not Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02316834Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment